Oruka Therapeutics, Inc. · NASDAQ:ORKA
Goncalves Joana sold 7,000 Oruka Therapeutics, Inc. shares (Form 4)
Traded Oct 15, 2026 · Filed Oct 15, 2026
On Oct 15, 2026, Goncalves Joana (Chief Medical Officer) sold 7,000 Oruka Therapeutics, Inc. shares at an average US$74.81 for US$524K under a trading plan, leaving 31,771 shares. Filed Oct 15, 2026 (Form 4).
- Sold
- 7,000 shares
- Price
- US$74.81 average (US$73.89 to US$77.71)
- Value
- US$524K
- Holding after
- 31,771 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Common Stock | Option exercise | 3,500 | US$6.84 | 35,271 | Direct |
| Oct 15, 2026 | Common Stock | Option exercise | 3,500 | US$7.80 | 38,771 | Direct |
| Oct 15, 2026 | Common Stock | Sale | 2,853 | US$73.89 | 35,918 | Direct |
| Oct 15, 2026 | Common Stock | Sale | 1,847 | US$74.69 | 34,071 | Direct |
| Oct 15, 2026 | Common Stock | Sale | 1,400 | US$75.48 | 32,671 | Direct |
| Oct 15, 2026 | Common Stock | Sale | 700 | US$76.67 | 31,971 | Direct |
| Oct 15, 2026 | Common Stock | Sale | 200 | US$77.71 | 31,771 | Direct |
Source
Download original · View original at SEC
Related
- Oruka Therapeutics, Inc.
- Goncalves Joana
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Goncalves Joana · Sep 15, 2026
- Form 4 · Goncalves Joana · Aug 17, 2026
- Form 4 · Goncalves Joana · Jul 15, 2026
- Form 4 · Goncalves Joana · Jun 15, 2026
- Form 4 · Goncalves Joana · May 15, 2026
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026
- Form 4 · Agarwal Arjun · Sep 21, 2026